“It came out of nowhere, it has spread everywhere and has basically killed our last resource of antibiotics, the last pill on the shelf, used to treat serious infections.”
A fungus living in the soils of Nova Scotia could offer new hope in the pressing battle against drug-resistant germs that kill tens of thousands of people every year, including one considered a serious global threat.
A team of researchers led by McMaster has discovered a fungus-derived molecule, known as AMA, which is able to disarm one of the most dangerous antibiotic-resistance genes: NDM-1 or New Delhi Metallo-beta-Lactamase-1, identified by the World Health Organization as a global public health threat.
“This is public enemy number one,” explains Gerry Wright, director of the Michael G. DeGroote Institute for Infectious Disease Research at McMaster University.
“It came out of nowhere, it has spread everywhere and has basically killed our last resource of antibiotics, the last pill on the shelf, used to treat serious infections,” he says.
Discovering the properties of the fungus-derived molecule is critical because it can provide a means to target and rapidly block the drug-resistant pathogens that render carbapenem antibiotics—a class of drugs similar to penicillin—ineffective.
“Simply put, the molecule knocks out NDM-1 so the antibiotics can do their job,” says Wright.
Seeking an answer to the riddle of resistance in the natural environment is a far more promising approach than trying to discover new antibiotics, a challenge which has perplexed scientists for decades. No new classes of antibiotics have been discovered since the late 1980s, leaving physicians with very few tools to fight life-threatening infections.
“Not only do we have the emergence of an antibiotic resistance gene that is targeting the last drug resource we have left, but it is carried by organisms that cause all sorts of challenging diseases and are multi-drug-resistant already. It has been found not only in clinics but in the environment—in contaminated water in South Asia—which has contributed to its spread over the globe,” explains Wright. “Our thinking was that if we could find a molecule that blocks NDM-1 then these antibiotics would be useful again.”
The Latest on: Superbugs
via Google News
The Latest on: Superbugs
- Go Team! IPs and Antimicrobial Stewardship Programs Take On Superbugson April 8, 2020 at 8:35 am
Throughout the evolution of antimicrobial stewardship (AMS) programs in healthcare, the role of the infection preventionist (IP) has not been clearly defined. AMS programs are an effort to coordinate ...
- Coronavirus shock: The everyday item a 'breeding ground' for life-threatening bugs exposedon April 3, 2020 at 2:05 am
As protection against the coronavirus infection, people around the world have been encouraged to be vigilant about their personal hygiene and that of their daily environments. However, a recent ...
- While you’re terrified of Covid-19, some climate alarmists are overjoyed because, for them, fear is… an OPPORTUNITYon April 1, 2020 at 1:34 am
They claim that global warming, species extinction, the emergence of superbugs and the eating of meat are somehow directly or indirectly linked to the outbreak of the current pandemic. They regard the ...
- Debate: How Can We Change Antimicrobial Use to Prevent the Rise of Superbugs?on March 30, 2020 at 11:02 am
Antimicrobial resistance could lead to the rise of superbugs, creating a global health security risk — the UN warned last year that the number of deaths caused by antimicrobial resistance could ...
- ContraFect to Chair and Participate in Virtual Superbugs & Superdrugs 2020 Conferenceon March 30, 2020 at 2:01 am
will virtually chair the opening day of the 22 nd Annual Superbugs & Superdrugs 2020 Conference. Dr. Cassino will also virtually present the Company’s anti-infective portfolio and platform ...
- ContraFect to Chair and Participate in Virtual Superbugs & Superdrugs 2020 Conferenceon March 30, 2020 at 2:00 am
ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new ...
- Sask. stops some screening for superbugs amidst coronavirus pandemic preparationon March 27, 2020 at 4:26 am
The Saskatchewan Health Authority says it's confident the risk of a superbug outbreak in the province is 'very low,' even as it suspends some screening during the COVID-19 pandemic. (Trevor ...
- Bedford pharmaceutical plant set to manufacture treatments against bacterial superbugson March 26, 2020 at 2:01 pm
Xellia Pharmaceuticals will produce Vancomycin, the gold standard of treatment against bacterial "superbugs" like MRSA, streptococci and c.difficile.
- SCYNEXIS to Virtually Present on the Candida Auris Treatment Landscape at the 22nd Annual Superbugs and Superdrugs Conference 2020on March 26, 2020 at 5:00 am
Candida auris is another growing and serious infectious global health threat that particularly impacts healthcare settings. In the United States there were more than 1,000 clinical cases and 2,000 ...
- 1 Week to Go to SMi’s 22nd Annual Superbugs & Superdrugs Conferenceon March 26, 2020 at 12:03 am
London, United Kingdom, March 26, 2020 --(PR.com)-- With only 1 week remaining, the 22nd Annual Superbugs & Superdrugs Conference will reconvene on March 30 and 31, with remote access only. This ...
via Bing News